Results 241 to 250 of about 227,212 (304)

Is serum angiotensin-converting enzyme a suitable biomarker for differentiating idiopathic and demyelinating optic neuritis? [PDF]

Saudi J Ophthalmol
Dehghani A, Hosseini NS, Mirmohammadkhani M, Irajpour M, Moayeri M, Amirkhani A, Esfahanian F, Pourazizi M.   +7 more
europepmc   +1 more source

Ancestry‐based antihypertensive therapy: Beware of pitfalls

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Meryam Sugulle, Patji Alnæs‐Katjavivi
wiley   +1 more source

The insulin‐like growth factor system and the progression of renal complications of type 2 diabetes

Diabetic Medicine, EarlyView.
Abstract Aims Chronic kidney disease is associated with dysregulation of the insulin‐like growth factor (IGF) system. Alterations in IGF bioavailability, driven by IGF binding proteins (IGFBPs), may influence the decline in renal function. However, the longitudinal relationship between baseline IGF‐I, IGF‐II, IGFBPs and progression of kidney ...
Adrian Heald, Yasitha lllangasekera, Andreas Matheou, Ram Prakash Narayanan, Stephen White, Hellena Habte‐Asres, Abigail Lay, Liliana Shalamanova, William Ollier, Graham A. Hitman, Ritwika Mallik, Philip A. Kalra, Martin Whyte, J. Martin Gibson   +13 more
wiley   +1 more source

Activation of Angiotensin-Converting Enzyme 2 Mitigates Gastrointestinal Acute Radiation Syndrome. [PDF]

Int J Radiat Oncol Biol Phys
Sharma GP, Nissen A, Gasperetti T, Foeckler J, Frei AC, Kuehn R, Gerhartz M, Heinzelman P, Romero PA, Zenga J, Himburg HA.   +10 more
europepmc   +1 more source

The burden of diabetic foot ulcers in a multi‐ethnic Asian cohort

Diabetic Medicine, EarlyView.
Abstract Aims Diabetic foot ulcers (DFUs) are a major source of morbidity among individuals with diabetes mellitus (DM), imposing a substantial burden on healthcare systems. Our institution established a multidisciplinary service aiming to facilitate early specialist intervention for DFU management.
Zongwen Wee, Yong Mong Bee, Sueziani Binte Zainudin   +2 more
wiley   +1 more source

The use of angiotensin-converting enzyme inhibitors in hospitalized patients with COVID-19 is associated with a lower risk of mortality. [PDF]

Sci Rep
Khalangot M, Gurianov V, Zakharchenko T, Kravchenko V, Kovzun O, Shupachynskiy V, Tronko M.   +6 more
europepmc   +1 more source

The burden of COVID‐19 in hospitalized people with diabetes mellitus in Brazil: Insights from four years of the pandemic

Diabetic Medicine, EarlyView.
Abstract Aims Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is more severe in people with diabetes mellitus due to immune dysfunction, exacerbated inflammation and increased risk of co‐morbidities and mortality.
Taís Mendes Camargo, Bianca Aparecida Siqueira, Luiz Felipe Azevedo Marques, Lucas Silva Mello, Fernando Augusto Lima Marson   +4 more
wiley   +1 more source

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers impact on the gut microbiome: a systematic review. [PDF]

Front Endocrinol (Lausanne)
Wang EM, Shremo Msdi A, Quach VN, Nguyen SQ, Quach E, Jo J, Eubank TA, Garey KW, Rosario N.   +8 more
europepmc   +1 more source

Underdiagnosed and Undertreated: Obesity and Its Cardiometabolic Burden in Swedish Clinical Practice—Insights From the AROS Database

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To quantify real‐world diagnosis and treatment of obesity in Sweden, describe cardiometabolic comorbidity burden across obesity classes, and compare long‐term cardiovascular outcomes with the general population. Materials and Methods This population‐based cohort study used the AROS (Analysis of Real‐world data of patients with Obesity in ...
Viveca Ritsinger, Magnus Sundbom, Jonatan Dereke, Åsa Ericsson, Thomas Cars, Maria K. Svensson, Anna Norhammar   +6 more
wiley   +1 more source

Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Angioedema Presenting After Long-Term Antihypertensive Therapy: A Case Report. [PDF]

Cureus
Khalid M, Nafis S.
europepmc   +1 more source